{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:07:57Z","timestamp":1792156077734,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008028","name":"School of Medicine and Public Health, University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12022-020-09626-1","type":"journal-article","created":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:02:35Z","timestamp":1589000555000},"page":"254-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms"],"prefix":"10.1007","volume":"31","author":[{"given":"Damodaran","family":"Narayanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Hardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Chanana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya","family":"Buehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo V.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"key":"9626_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cncr.23542","volume":"113","author":"BI Gustafsson","year":"2008","unstructured":"Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer. 2008;113:5\u201321.","journal-title":"Cancer."},{"key":"9626_CR2","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1002\/cncr.24498","volume":"115","author":"EM Bertino","year":"2009","unstructured":"Bertino EM, Confer PD, Colonna JE, Ross P, Otterson GA. Pulmonary neuroendocrine\/carcinoid tumors: a review article. Cancer. 2009;115:4434\u201341.","journal-title":"Cancer."},{"issue":"Suppl 7","key":"9626_CR3","doi-asserted-by":"publisher","first-page":"vii65","DOI":"10.1093\/annonc\/mdq380","volume":"21","author":"WD Travis","year":"2010","unstructured":"Travis WD. Advances in neuroendocrine lung tumors. Ann Oncol. 2010;21 Suppl 7:vii65-71.","journal-title":"Ann Oncol"},{"key":"9626_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.21037\/tlcr.2017.09.04","volume":"6","author":"G Pelosi","year":"2017","unstructured":"Pelosi G, Sonzogni A, Harari S, Albini A, Bresaola E, Marchi\u00f2 C, et al. Classification of pulmonary neuroendocrine tumors: new insights. Transl Lung Cancer Res. 2017;6:513\u201329.","journal-title":"Transl Lung Cancer Res."},{"key":"9626_CR5","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31:1770\u201386.","journal-title":"Mod Pathol."},{"key":"9626_CR6","first-page":"6068","volume":"50","author":"SM Jensen","year":"1990","unstructured":"Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res. 1990;50:6068\u201374.","journal-title":"Cancer Res."},{"key":"9626_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","volume":"144","author":"JN Rosenbaum","year":"2015","unstructured":"Rosenbaum JN, Guo Z, Baus RM, Werner H, Rehrauer WM, Lloyd RV. INSM1: A novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms. Am J Clin Pathol. 2015;144:579\u201391.","journal-title":"Am J Clin Pathol."},{"key":"9626_CR8","doi-asserted-by":"crossref","unstructured":"Kim D, Viswanathan K, Goyal A, Rao R. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors. Cancer Cytopathol. 2020","DOI":"10.1002\/cncy.22242"},{"key":"9626_CR9","doi-asserted-by":"crossref","unstructured":"Staaf J, Tran L, S\u00f6derlund L, Nodin B, Jirstr\u00f6m K, Vidarsdottir H, et al. Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers: a comprehensive study and review of the literature. Arch Pathol Lab Med. 2020","DOI":"10.5858\/arpa.2019-0250-OA"},{"key":"9626_CR10","doi-asserted-by":"crossref","unstructured":"Kim IE, Amin A, Wang LJ, Cheng L, Perrino CM. Insulinoma-associated protein 1 (INSM1) expression in small cell neuroendocrine carcinoma of the urinary tract. Appl Immunohistochem Mol Morphol. 2019","DOI":"10.1158\/1538-7445.AM2020-5434"},{"key":"9626_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jasc.2019.06.002","volume":"8","author":"K Viswanathan","year":"2019","unstructured":"Viswanathan K, Siddiqui MT, Borczuk AC. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens. J Am Soc Cytopathol. 2019;8:299\u2013308.","journal-title":"J Am Soc Cytopathol."},{"key":"9626_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.14740\/gr1138","volume":"12","author":"C Yang","year":"2019","unstructured":"Yang C, Gonzalez I, Zhang L, Cao D. Neuroendocrine markers insulinoma-associated protein 1, chromogranin, synaptophysin, and CD56 show rare positivity in adenocarcinoma ex-goblet cell carcinoids. Gastroenterology Res. 2019;12:120\u20137.","journal-title":"Gastroenterology Res."},{"key":"9626_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.anndiagpath.2019.04.002","volume":"40","author":"C Leblebici","year":"2019","unstructured":"Leblebici C, Yeni B, Savli TC, Ayd\u0131n \u00d6, G\u00fcne\u015f P, Cinel L, et al. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for merkel cell carcinoma: evaluation of 24 cases. Ann Diagn Pathol. 2019;40:53\u20138.","journal-title":"Ann Diagn Pathol."},{"key":"9626_CR14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/his.13458","volume":"72","author":"JK Dermawan","year":"2018","unstructured":"Dermawan JK, Mukhopadhyay S. Insulinoma-associated protein 1 (INSM1) differentiates carcinoid tumourlets of the lung from pulmonary meningothelial-like nodules. Histopathology. 2018;72:1067\u20139.","journal-title":"Histopathology."},{"key":"9626_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41379-018-0122-7","volume":"32","author":"S Mukhopadhyay","year":"2019","unstructured":"Mukhopadhyay S, Dermawan JK, Lanigan CP, Farver CF. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections. Mod Pathol. 2019;32:100\u20139.","journal-title":"Mod Pathol."},{"key":"9626_CR16","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1016\/j.ajpath.2015.08.018","volume":"185","author":"K Fujino","year":"2015","unstructured":"Fujino K, Motooka Y, Hassan WA, Ali Abdalla MO, Sato Y, Kudoh S, et al. Insulinoma-associated protein 1 is a crucial regulator of neuroendocrine differentiation in lung cancer. Am J Pathol. 2015;185:3164\u201377.","journal-title":"Am J Pathol."},{"key":"9626_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/cncy.22164","volume":"127","author":"T Nakra","year":"2019","unstructured":"Nakra T, Nambirajan A, Guleria P, Phulware RH, Jain D. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears. Cancer Cytopathol. 2019;127:539\u201348.","journal-title":"Cancer Cytopathol."},{"key":"9626_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12022-018-9559-y","volume":"30","author":"M Roy","year":"2019","unstructured":"Roy M, Buehler DG, Zhang R, Schwalbe ML, Baus RM, Salamat MS, et al. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites. Endocr Pathol. 2019;30:35\u201342.","journal-title":"Endocr Pathol."},{"key":"9626_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/cup.13079","volume":"45","author":"PS Rush","year":"2018","unstructured":"Rush PS, Rosenbaum JN, Roy M, Baus RM, Bennett DD, Lloyd RV. Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma). J Cutan Pathol. 2018;45:129\u201335.","journal-title":"J Cutan Pathol."},{"key":"9626_CR20","first-page":"1","volume":"2017","author":"M Xue","year":"1617","unstructured":"Xue M, Zhuo Y, Shan B. MicroRNAs, long noncoding RNAs, and their functions in human disease. Methods Mol Biol. 2017;1617:1\u201325.","journal-title":"Methods Mol Biol."},{"key":"9626_CR21","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965\u201381.","journal-title":"Cancer Res."},{"key":"9626_CR22","doi-asserted-by":"publisher","first-page":"35939","DOI":"10.1038\/srep35939","volume":"6","author":"C-H Wu","year":"2016","unstructured":"Wu C-H, Hsu C-L, Lu P-C, Lin W-C, Juan H-F, Huang H-C. Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules. Sci Rep. 2016;6:35939.","journal-title":"Sci Rep"},{"key":"9626_CR23","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.2147\/OTT.S121785","volume":"9","author":"Z Peng","year":"2016","unstructured":"Peng Z, Zhang C, Duan C. Functions and mechanisms of long noncoding RNAs in lung cancer. Onco Targets Ther. 2016;9:4411\u201324.","journal-title":"Onco Targets Ther."},{"key":"9626_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12022-017-9507-2","volume":"29","author":"R Zhang","year":"2018","unstructured":"Zhang R, Hardin H, Huang W, Buehler D, Lloyd RV. Long non-coding RNA Linc-ROR is upregulated in papillary thyroid carcinoma. Endocr Pathol. 2018;29:1\u20138.","journal-title":"Endocr Pathol."},{"key":"9626_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12022-019-09589-y","volume":"30","author":"Y Wang","year":"2019","unstructured":"Wang Y, Hardin H, Chu Y-H, Esbona K, Zhang R, Lloyd RV. Long non-coding RNA expression in anaplastic thyroid carcinomas. Endocr Pathol. 2019;30:262\u20139.","journal-title":"Endocr Pathol."},{"key":"9626_CR26","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ajpath.2014.04.011","volume":"184","author":"H Hardin","year":"2014","unstructured":"Hardin H, Guo Z, Shan W, Montemayor-Garcia C, Asioli S, Yu X-M, et al. The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression. Am J Pathol. 2014;184:2342\u201354.","journal-title":"Am J Pathol."},{"key":"9626_CR27","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.ajpath.2016.02.003","volume":"186","author":"H Hardin","year":"2016","unstructured":"Hardin H, Yu X-M, Harrison AD, Larrain C, Zhang R, Chen J, et al. Generation of novel thyroid cancer stem-like cell clones: effects of resveratrol and valproic acid. Am J Pathol. 2016;186:1662\u201373.","journal-title":"Am J Pathol."},{"key":"9626_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0024-3205(88)90521-8","volume":"43","author":"JE Taylor","year":"1988","unstructured":"Taylor JE, Coy DH, Moreau JP. High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69). Life Sci. 1988;43:421\u20137.","journal-title":"Life Sci."},{"key":"9626_CR29","first-page":"23","volume":"58","author":"A Kasprzak","year":"2007","unstructured":"Kasprzak A, Zabel M, Biczysko W. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours. Pol J Pathol. 2007;58:23\u201333.","journal-title":"Pol J Pathol."},{"key":"9626_CR30","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1097\/PAS.0000000000000916","volume":"41","author":"LM Rooper","year":"2017","unstructured":"Rooper LM, Sharma R, Li QK, Illei PB, Westra WH. INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity. Am J Surg Pathol. 2017;41:1561\u20139.","journal-title":"Am J Surg Pathol."},{"key":"9626_CR31","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/modpathol.3800659","volume":"19","author":"K Hiroshima","year":"2006","unstructured":"Hiroshima K, Iyoda A, Shida T, Shibuya K, Iizasa T, Kishi H, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol. 2006;19:1358\u201368.","journal-title":"Mod Pathol."},{"key":"9626_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/his.13800","volume":"74","author":"JL Derks","year":"2019","unstructured":"Derks JL, Dingemans A-MC, van Suylen R-J, den Bakker MA, Damhuis RAM, van den Broek EC, et al. Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens? Histopathology. 2019;74:555\u201366.","journal-title":"Histopathology."},{"key":"9626_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli M-T, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96:1297\u2013325.","journal-title":"Physiol Rev."},{"key":"9626_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s11658-019-0192-7","volume":"24","author":"S Yang","year":"2019","unstructured":"Yang S, Liu T, Sun Y, Liang X. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p. Cell Mol Biol Lett. 2019;24:70.","journal-title":"Cell Mol Biol Lett."},{"key":"9626_CR35","first-page":"533","volume":"19","author":"L Wu","year":"2020","unstructured":"Wu L, Liu C, Zhang Z. Knockdown of lncRNA MIAT inhibits proliferation and cisplatin resistance in non-small cell lung cancer cells by increasing miR-184 expression. Oncol Lett. 2020;19:533\u201341.","journal-title":"Oncol Lett."},{"key":"9626_CR36","first-page":"153","volume":"15","author":"D Moris","year":"2018","unstructured":"Moris D, Ntanasis-Stathopoulos I, Tsilimigras DI, Adam MA, Yang C-FJ, Harpole D, et al. Insights into novel prognostic and possible predictive biomarkers of lung neuroendocrine tumors. Cancer Genomics Proteomics. 2018;15:153\u201363.","journal-title":"Cancer Genomics Proteomics."},{"key":"9626_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/PAS.0000000000001358","volume":"44","author":"JKT Dermawan","year":"2020","unstructured":"Dermawan JKT, Farver CF. The role of histologic grading and Ki-67 index in predicting outcomes in pulmonary carcinoid tumors. Am J Surg Pathol. 2020;44:224\u201331.","journal-title":"Am J Surg Pathol."},{"key":"9626_CR38","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/modpathol.2014.74","volume":"27","author":"FD Mairinger","year":"2014","unstructured":"Mairinger FD, Ting S, Werner R, Walter RFH, Hager T, Vollbrecht C, et al. Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study. Mod Pathol. 2014;27:1632\u201340.","journal-title":"Mod Pathol."},{"key":"9626_CR39","doi-asserted-by":"crossref","unstructured":"Demes M, Aszyk C, Bartsch H, Schirren J, Fisseler-Eckhoff A. Differential miRNA-expression as an adjunctive diagnostic tool in neuroendocrine tumors of the lung. Cancers (Basel). 2016;8.","DOI":"10.3390\/cancers8040038"},{"key":"9626_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/labinvest.2015.123","volume":"96","author":"S Fang","year":"2016","unstructured":"Fang S, Gao H, Tong Y, Yang J, Tang R, Niu Y, et al. Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells. Lab Invest. 2016;96:60\u20138.","journal-title":"Lab Invest."},{"key":"9626_CR41","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/cam4.220","volume":"3","author":"H Ono","year":"2014","unstructured":"Ono H, Motoi N, Nagano H, Miyauchi E, Ushijima M, Matsuura M, et al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med. 2014;3:632\u201342.","journal-title":"Cancer Med."},{"key":"9626_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-014-0090-4","volume":"7","author":"G Loewen","year":"2014","unstructured":"Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7:90.","journal-title":"J Hematol Oncol."},{"key":"9626_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/1471-2407-13-461","volume":"13","author":"K Lu","year":"2013","unstructured":"Lu K, Li W, Liu X, Sun M, Zhang M, Wu W, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461.","journal-title":"BMC Cancer."},{"key":"9626_CR44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.canlet.2016.03.003","volume":"375","author":"A Zhang","year":"2016","unstructured":"Zhang A, Zhang J, Kaipainen A, Lucas JM, Yang H. Long non-coding RNA: A newly deciphered \u201ccode\u201d in prostate cancer. Cancer Lett. 2016;375:323\u201330.","journal-title":"Cancer Lett."}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-020-09626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-020-09626-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-020-09626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T23:40:27Z","timestamp":1620517227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-020-09626-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9626"],"URL":"https:\/\/doi.org\/10.1007\/s12022-020-09626-1","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,9]]},"assertion":[{"value":"9 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board at the University of Wisconsin-Madison.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}